Angstrom medica: Securing FDA approval and commercializing a nanomedical device

Nanotechnology Law and Business

Volumn 2, Issue 2, 2005, Pages 168-173

  Baluch, Andrew S ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Technology Transfer Program

Author keywords

[No Author keywords available]

Indexed keywords

BUSINESS STRATEGY; DRUG DELIVERY; NANOSCALE MATERIALS;

DRUG PRODUCTS; MATHEMATICAL MODELS; NANOSTRUCTURED MATERIALS; PATENTS AND INVENTIONS; STRATEGIC PLANNING;

NANOTECHNOLOGY;

EID: 30544442644     PISSN: 15462080     EISSN: 15462080     Source Type: Trade Journal    
DOI: None     Document Type: Article

References (1)

1. Angstrom Medica, Inc., 150-A New Boston St., Woburn, MA 01801, www.angstrommedica.com. Paul Mraz, Chief Executive Officer ("CEO"), can be reached atpmraz@angstrommedica.com.